A novel entecavir-resistant virus with patient of lamivudine-resistant hepatitis B virus mutant
暂无分享,去创建一个
Yoshiyuki Suzuki | K. Ikeda | H. Kumada | Y. Arase | T. Hosaka | F. Suzuki | H. Sezaki | N. Akuta | S. Saitoh | T. Someya | S. Watahiki | Mizuho Kobayashi | J. Satoh
[1] P. Angus,et al. Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine , 2004, Antimicrobial Agents and Chemotherapy.
[2] Yoshiyuki Suzuki,et al. Efficacy of Lamivudine Therapy and Factors Associated with Emergence of Resistance in Chronic Hepatitis B Virus Infection in Japan , 2003, Intervirology.
[3] William M. Lee,et al. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. , 2004, Gastroenterology.